Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 24, 2026

JDE Peet’s reports full-year results 2025

View original at globenewswire.com
JDE Peet’s reports full-year results 2025 Strong financial performance and strategic progress in volatile and challenging environment PRESS RELEASE Amsterdam, February 24, 2026 Key items1 Organic sales up +15.3%, driven by 19.5% price and -4.3% volume/mix; Reported sales up 12.3%Organic adjusted EBIT up +1.2% to EUR 1…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • JDE Peet's remains committed to creating value across the entire supply chain, supporting coffee farmers in adopting sustainable practices while delivering innovative, high-quality coffee products

    80% confidence
  • The Reignite the Amazing strategy is already delivering tangible results since its launch

    80% confidence
  • Board of Directors does not propose a dividend for financial year 2025 in light of the ongoing acquisition process

    80% confidence
  • Company is preparing to build the world's best coffee company together with KDP and enter a new era of growth and innovation

    80% confidence
  • 2025 was a very good year for JDE Peet's despite unprecedented green coffee inflation, delivering strong top-line growth, increased operational profit, and generating cash in excess of 1.1 billion euro

    80% confidence
  • JDE Peet's Board of Directors fully supports and unanimously recommends the KDP offer to all shareholders for acceptance

    80% confidence
  • JDE Peet's enters 2026 from a position of strength based on strong 2025 performance and strategic momentum

    80% confidence
  • JDE Peet's is the world's leading pure-play coffee company

    80% confidence
  • Closing of the KDP acquisition offer is expected early in the second quarter of 2026, subject to satisfaction or waiver of closing conditions

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com